Venous Thromboembolism: Past, Present and Future

ABSTRACT

Over the last four decades there have been remarkable advances in the diagnosis and treatment of venous thromboembolism (VTE)-pulmonary embolism (PE) and deep venous thrombosis (DVT). We have moved from no objective documentation to a plethora of ever improving imaging studies. Evolving treatment modalities have reduced the mortality due to PE to ~2%. Shorter hospitalizations followed by outpatient therapy are a growing reality. The use of primary prophylaxis is increasing, but more widespread use must be encouraged. Despite the many accomplishments, too many patients with VTE with its high mortality without treatment remain undiagnosed. There is a critical need to improve the role of the patient's history in identifying patients who warrant objective testing. The ideal would be the development of a biological marker of VTE, similar to the creatinine kinase-MB, creatinine kinase-MM, or troponin I in acute myocardial infarction.

KEYWORD

Venous thromboembolism - pulmonary embolism - deep venous thrombosis

REFERENCES

• 1 Stein P D, Terrin M L, Hales C A. Clinical, laboratory, roentgenographic and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease.  Chest . 1991;  100 598-603
• 2 Neuhaus A, Bentz R R, Weg J G. Pulmonary embolism in respiratory failure.  Chest . 1978;  73 460-465
• 3 Goldhaber S Z, Hennekens C H, Evans D A. Factors associated with correct antemortem diagnosis of major pulmonary embolism.  Am J Med . 1982;  73 822-826
• 4 Stein P D, Henry J W. Prevalence of acute pulmonary embolism among patients in a general hospital at autopsy.  Chest . 1995;  108 978-981
• 5 Wagner H N, Sabiston Jr C D, McAfee J G. Diagnosis of massive pulmonary embolism in man by radioisotope scanning.  N Engl J Med . 1964;  271 377-384
• 6 Wagner H N, Lopez-Majano V, Langam J K. Radioactive xenon in the differential diagnosis of pulmonary embolism.  Radiology . 1968;  91 1168-1174
• 7 Moser K M, Guisan M, Cuomo A. Differentiation of pulmonary vascular from parenchymal diseases by ventilation/perfusion scintiphotography.  Ann Intern Med . 1971;  75 597-605
• 8 Sasahara A A, Stein M, Simon M. Pulmonary angiography in the diagnosis of thromboembolic disease.  N Engl J Med . 1964;  270 1075-1081
• 9 Stein P D, O'Connor J F, Dalen J E. The angiographic diagnosis of acute pulmonary embolism: evaluation of criteria.  Am Heart J . 1967;  73 730-741
• 10 Bookstein J J, Silver T M. The angiographic differential diagnosis of acute pulmonary embolism.  Radiology . 1974;  110 25-33
• 11 McNeil B J. A diagnostic strategy using ventilation-perfusion studies in patients suspect for pulmonary embolism.  J Nucl Med . 1976;  17 613-616
• 12 Bell W R, Simon T L. A comparative analysis of pulmonary perfusion scans with pulmonary angiograms.  Am Heart J . 1976;  92 700-706
• 13 The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: result of the prospective investigators of pulmonary embolism diagnosis (PIOPED).  JAMA . 1990;  263 2753-2759
• 14 Berberich J, Hirsch S. Die roentgenologische Darstellung der Arterien und Venen im lebenden Menschen.  Klin Wochenschr . 1923;  2 2226-2228
• 15 Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg.  Arch Surg . 1972;  104 134-144
• 16 Landefeld C S, McGuire E, Cohen A M. Clinical findings associated with acute proximal deep vein thrombosis: a basis for quantifying clinical judgment.  Am J Med . 1990;  92 582
• 17 Nicolaides A N, Meadway J, Irving D. The value of the clinical diagnosis of deep venous thrombosis. In: Nicolaides A ed. Thromboembolism Etiology: Advances in Prevention Management. Baltimore: University Park Press 1975
• 18 Wheeler H B, Anderson Jr A F, Cardullo P A. Suspected deep vein thrombosis: management by impedance plethysmography.  Arch Surg . 1982;  117 1206-1209
• 19 Lensing A WA, Doris C I, McGrath F P. A comparison of compression ultrasound with color Doppler ultrasound for the diagnosis of symptomless postoperative deep vein thrombosis.  Arch Intern Med . 1997;  157 765-768
• 20 Murray G DW, Best C H. The use of heparin in thrombosis.  Ann Surg . 1947;  108 163-177
• 21 Bauer G. Thrombosis: early diagnosis and abortive treatment with heparin.  Lancet . 1946;  1 448-454
• 22 Barritt D W, Jordan S C. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial.  Lancet . 1960;  1 1309-1312
• 23 Butt H R, Allen E V, Bollman J L. A preparation from spoiled sweet clover [331 methylene-bis-(+hydroxycoumarin)] which prolongs coagulation and prothrombic time of the blood: preliminary report of experimental and clinical studies.  Proc Staff Meet Mayo Clin . 1941;  16 388-395
• 24 Allen E V, Hines Jr A E, Kvale W F. The use of dicumarol as an anticoagulant: experience in 2307 cases.  Ann Intern Med . 1947;  27 371-381
• 25 Sevitt S, Gallagher N G. Prevention of venous thrombosis and pulmonary embolism in injured patients.  Lancet . 1959;  1 981-989
• 26 Hirsch J, Dalen J E, Deykin D. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range.  Chest . 1995;  108 231S-246S
• 27 Hyers T M, Agnelli G, Hull R D. Sixth ACCP consensus conference on antithrombotic therapy: antithrombotic therapy for venous thromboembolism disease.  Chest. in press; 
• 28 Girard P, Musset D, Parent F. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism.  Chest . 1999;  116 903-908
• 29 van Rossum B A, van Houwelingen C H, Kieft G J. Prevalence of deep vein thrombosis in suspected and proven pulmonary embolism: a meta-analysis.  Br J Radiol . 1998;  71 1260-1265
• 30 Weg J G. Venous thromboembolism in pregnancy.  Semin Respir Crit Care Med . 1998;  19 231-241
• 31 Ferrari E, Chevallier T, Chapelier A. Travel as a risk factor for venous thromboembolic disease: a case-control study.  Chest . 1999;  115 440-444
• 32 Koster T, Rosendaal F R, deRonde H. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study.  Lancet . 1993;  342 1503-1506
• 33 Svenson P J, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis.  N Engl J Med . 1994;  330 517-522
• 34 Dahlback B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.  Proc Natl Acad Sci USA . 1994;  91 1396-1400
• 35 Ridker P M, Miletich J P, Hennekens C H. Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening.  JAMA . 1997;  277 1305-1307
• 36 Rosendaal F R, Siscovick D S, Schwartz S M. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women.  Blood . 1994;  90 1747-1750
• 37 Fermo I, D'Angelo S V, Paroni R. Prevalence of moderate hyperhomocystenemia in patients with early onset venous and arterial occlusive disease.  Ann Intern Med . 1995;  123 747-753
• 38 Goddijn-Wessel T A, Wouters M G, Van de Molenef S. A risk factor for placental abruption or infarction.  Eur J Obstet Gynecol Reprod Biol . 1996;  66 23-29
• 39 Wouters M G, Boers G H, Blom H J. Hyperhomocystenemia: a risk factor along with unexplained recurrent early pregnancy loss.  Fertil Steril . 1993;  60 820-825
• 40 Kearon C, Crowther M, Hirsh J. Management of patients with hereditary hypercoagulable disorders.  Annu Rev Med . 2000;  51 169-185
• 41 Lockshin M D. Antiphospholipid antibody syndrome.  Rheum Dis Clin North Am . 1994;  20 45-59
• 42 Ginsberg K S, Wells P S, Brill-Edwards P. Antiphospholipid antibodies and venous thromboembolism.  Blood . 1995;  86 3685-3691
• 43 Petri M. Pathogenesis and the treatment of the antiphospholipid antibody syndrome.  Adv Rheum . 1997;  81 151-177
• 44 Waterstone J J, Summers B A, Hoskins M C. Ovarian hyperstimulation syndrome and deep cerebral venous thrombosis.  Br J Obstet Gynaecol . 1992;  99 439-440
• 45 Fournet N, Surrey E, Kerin J. Internal jugular vein thrombosis after ovulation induction with gonadotropins.  Fertil Steril . 1991;  56 354-356
• 46 Lesser B A, Leeper Jr V K, Stein P D. The diagnosis of acute pulmonary embolism in patients with chronic obstructive pulmonary disease.  Chest . 1992;  102 17-22
• 47 Miniati M, Pistolesi M, Marini C. Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISA-PED).  Am J Respir Crit Care Med . 1996;  154 1387-1393
• 48 Stein P D, Athanasoulis C, Alavi A. Complications and validity of pulmonary angiography in acute pulmonary embolism.  Circulation . 1992;  85 462-468
• 49 Heijboer H, Buller H R, Lensing A W. A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients.  N Engl J Med . 1993;  329 1365-1369
• 50 Hull R D, Hirsch J, Carter C J. Diagnostic efficacy of impedance plethysmography for clinically suspected deep vein thrombosis.  Ann Intern Med . 1985;  102 21-28
• 51 Huisman M V, Buller H R, Ten Cate W J. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients: the Amsterdam General Practitioner Study.  N Engl J Med . 1986;  314 823-828
• 52 Tapson V F, Carroll B A, Davidson B L. The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society.  Am J Respir Crit Care Med . 1999;  160 1043-1066
• 53 Comerota A J, Katz M L, Hashemi H A. Venous duplex imaging for the diagnosis of acute deep venous thrombosis.  Haemostasis . 1993;  23(Suppl 1) 61-71
• 54 Lensing A W, Prandoni P, Brandjes D. Detection of deep-vein thrombosis by real-time B-mode ultrasonography.  N Engl J Med . 1989;  320 342-345
• 55 Messina L M, Sarpa M S, Smith M A. Clinical significance of routine imaging of iliac and calf veins by color flow duplex scanning in patients suspected of having acute lower extremity deep venous thrombosis.  Surgery . 1993;  114 921-927
• 56 Remy-Jardin M, Remy J, Artaud D. Spiral CT of pulmonary embolism: diagnostic approach, interpretive pitfalls and current indications.  Eur Radiol . 1998;  8 1376-1390
• 57 Mullins M D, Becker D M, Hagspiel K D. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism.  Arch Intern Med . 2000;  160 293-298
• 58 Rathbun S W, Raskob G E, Whisett T L. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review.  Ann Intern Med . 2000;  132 227-232
• 59 Oser R F, DA Zuckerman, Gutierrez F R. Anatomic distribution of pulmonary emboli at pulmonary angiography: implications for cross-sectional imaging.  Radiology . 1996;  199 31-35
• 60 Stein P D, Henry J W. Prevalence of acute pulmonary embolism in central and subsegmental pulmonary arteries and relation to probability interpretation of ventilation-perfusion lung scans.  Chest . 1997;  111 1246-1248
• 61 Meaney J F, Weg J G, Chenevert T L. Diagnosis of pulmonary embolism with magnetic resonance angiography.  N Engl J Med . 1997;  336 1422-1427
• 62 Gupta A, Frazer C K, Ferguson J M. Acute pulmonary embolism: diagnosis with MR angiography.  Radiology . 1999;  210 353-359
• 63 Sostman H D, Layish D T, Tapson V F. Prospective comparison of helical CT and MR imaging in clinically suspected acute pulmonary embolism.  J Magn Reson Imaging . 1996;  6 275-281
• 64 Kubik-Huch R A, Hebisch G, Huch R. Role of duplex color Doppler ultrasound, computed tomography, and MR angiography in the diagnosis of septic puerperal ovarian vein thrombosis.  Abdom Imaging . 1999;  24 85-91
• 65 Ginsberg J S, Wells P S, Kearon C. Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism.  Ann Intern Med . 1998;  129 1006-1011
• 66 Heit J A, Minor T A, Andrews J C. Determinants of plasma fibrin D-dimer sensitivity for acute pulmonary embolism as defined by pulmonary angiography.  Arch Pathol Lab Med . 1999;  123 235-240
• 67 Oger E, Leroyer C, Bressollette L. Evaluation of a new, rapid, and quantitative D-dimer test in patients with suspected pulmonary embolism.  Am J Respir Crit Care Med . 1998;  158 65-70
• 68 Kollef M H, Zahid M, Eisenberg P R. Predictive value of a rapid semiquantitative D-dimer assay in critically ill patients with suspected venous thromboembolic disease.  Crit Care Med . 2000;  28 414-420
• 69 Farrell S, Hayes T, Shaw M. A negative SimpliREd D-dimer assay result does not exclude the diagnosis of deep vein thrombosis or pulmonary embolus in emergency department patients.  Ann Emerg Med . 2000;  35 121-125
• 70 Francalanci I, Comeglio P, Alessandrello Liotta A. D-dimer plasma levels during normal pregnancy measured by specific ELISA.  Int J Clin Lab Res . 1997;  27 65-67
• 71 Jardin F, Dubourg O, Bourdarias J-P. Echocardiographic pattern of acute cor pulmonale.  Chest . 1997;  111 209-217
• 72 Krivee B, Voga G, Zuran I. Diagnosis and treatment of shock due to massive pulmonary embolism.  Chest . 1997;  112 1310-1316
• 73 Viellard-Baron A, Qanadli S D, Antakly Y. Transesophageal echocardiography for the diagnosis of pulmonary embolism with acute cor pulmonale: a comparison with radiological procedures.  Intensive Care Med . 1998;  24 429-433
• 74 Pruszczyk P, Torbicki A, Pacho R. Noninvasive diagnosis of suspected severe pulmonary embolism.  Chest . 1997;  112 722-728
• 75 Dolovich L R, Ginsberg J S, Douketis J D. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency.  Arch Intern Med . 2000;  160 181-188
• 76 A Collaborative European Multicentre Study. A randomized trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis.  Thromb Haemost . 1991;  65 251-256
• 77 Abada J, Nieuwenhuis H K, Sixma J J. Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin): results of a double-blind randomized study.  Circulation . 1989;  80 935-940
• 78 Bratt G, Aberg W, Johansson M. Two daily subcutaneous injections of Fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT).  Thromb Haemost . 1990;  64 506-510
• 79 Bratt G, Tornebohm E, Granqvist S. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis.  Thromb Haemost . 1985;  54 813-817
• 80 Holm H A, Ly B, Handeland G F. Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.  Haemostasis . 1986;  16 30-37
• 81 Albada J, Neuwenhuis H K, Sixma J J. Comparison of intravenous standard heparin and Fragmin in the treatment of venous thromboembolism: a randomized double-blind study.  Thromb Res . 1987;  7(Suppl) 24
• 82 Simonneau G, Charbonnier B, Decousus H. Subcutaneous low molecular weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.  Arch Intern Med . 1993;  153 1541-1546
• 83 Handeland G F, Abildgaard U, Holm H A. Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.  Eur J Clin Pharmacol . 1990;  39 107-112
• 84 Prandoni P, Lensing A W, Buller H R. Comparison of subcutaneous low molecular weight heparin with intravenous standard heparin in proximal vein thrombosis.  Lancet . 1992;  339 441-445
• 85 Hull R D, Raskob G E, Pineo G F. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the proximal-vein thrombosis.  N Engl J Med . 1992;  326 975-982
• 86 Lindmarker P, Holstrom M, Granqvist S. Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis.  Thromb Haemost . 1994;  72 186-190
• 87 Luomanmaki K, Granqvist S, Hallert C. A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis.  J Intern Med . 1996;  240 85-92
• 88 Kirrchmaier C M, Wolf H, Scheafer H. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certopain Study Group.  Int Angiol . 1998;  17 135-145
• 89 Meyer G, Brenot F, Pacouret G. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study.  Thromb Haemost . 1995;  74 1432-1435
• 90 Siragusa S, Cosmi B, Piovella F. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis.  Am J Med . 1996;  100 269-277
• 91 Gould M K, Dembitzer A D, Doyle R L. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis.  Ann Intern Med . 1999;  130 800-809
• 92 Hull R D, Raskob G E, Brant R F. Low molecular weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group.  Arch Intern Med . 2000;  160 229-236
• 93 Brandjes D P, Buller H R, Heijboer H. Randomized trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis.  Lancet . 1997;  349 759-762
• 94 Carson J L, Kelley M A, Duff A. The clinical course of pulmonary embolism.  N Engl J Med . 1992;  326 1240-1245
• 95 Douketis J D, Kearon C, Bates S. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.  JAMA . 1998;  279 458-462
• 96 Hyers T M. Venous thromboembolism.  Am J Respir Crit Care Med . 1999;  159 1-14
• 97 Casele H L, Laifer S A, Woelkers D A. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy.  Am J Obstet Gynecol . 1999;  181 1113-1117
• 98 Levine M, Gent M, Hirsh J. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.  N Engl J Med . 1996;  334 677-681
• 99 Koopman M M, Prandoni P, Piovella F. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.  N Engl J Med . 1996;  334 682-687
• 100 Kovacs M J, Anderson D, Morrow B. Outpatient treatment of pulmonary embolism with dalteparin.  Thromb Haemost . 2000;  83 209-211
• 101 Dunn A S, Coller B. Outpatient treatment of deep vein thrombosis: Translating clinical trials into practice.  Am J Med . 1999;  106 660-669
• 102 Penner J A. Experience with a thrombin clotting time assay for measuring heparin activity.  Am J Clin Pathol . 1974;  61 645-653
• 103 Baker B A, Adelman M D, Smith P A. Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assays.  Arch Intern Med . 1997;  157 2475-2479
• 104 Krulder J WM, de Boer A, van den Besselaar A H P M. Diurnal rhythm in anticoagulant effect of heparin during low dose constant rate infusion.  Thromb Haemost . 1998;  68 30-32
• 105 Kearon C, Johnston M, Moffat K. Effect of warfarin on activated partial thromboplastin time in patients receiving heparin.  Arch Intern Med . 1998;  158 1140-1143
• 106 Delorme M A, Inwood M J, O'Keefe B. Sensitivity of the thrombin clotting time and activated partial thromboplastin time to low level of antithrombin III during heparin therapy.  Clin Lab Haemat . 1990;  12 433-436
• 107 Hull R D, Raskob G E, Rosenbloom D. Optimal therapeutic level of heparin therapy in patients with venous thrombosis.  Arch Intern Med . 1992;  152 1589-1595
• 108 Hull R D, Raskob G E, Hirsh J. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.  N Engl J Med . 1986;  315 1109-1114
• 109 Hull R D, Raskob G E, Brant R F. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.  Arch Intern Med . 1997;  157 2562-2568
• 110 Hull R, Hirsh J, Jay R. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.  N Engl J Med . 1982;  307 1676-1681
• 111 Schulman S, Granqvist S, Holmstrom M. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.  N Engl J Med . 1997;  336 393-398
• 112 Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep vein thrombosis and pulmonary embolism.  Lancet . 1992;  340 873-876
• 113 Kearon C, Gent M, Hirsh J. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.  N Engl J Med . 1999;  340 901-907
• 114 Schulman S, AS Rhedin, P Lindmarker, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.  N Engl J Med . 1995;  332 1661-1665
• 115 Toglia M R, Weg J G. Venous thromboembolism during pregnancy.  N Engl J Med . 1996;  335 108-114
• 116 Eriksson B I, Wille-Jorgensen P, Kalebo P. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.  N Engl J Med . 1997;  337 1329-1335
• 117 Schiele F, Vuillemenot A, Kramarz P. Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia.  Am J Hematol . 1995;  50 20-25
• 118 Greinacher A, Volpel H, Janssens U. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.  Circulation . 1999;  99 73-80
• 119 Lewis B E, Walenga J M, Wallis D E. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and thrombosis syndrome.  Semin Thromb Hemost . 1997;  23 197-202
• 120 Urokinase Pulmonary Embolism Trial. Phase I results.  JAMA . 1970;  214 2163-2172
• 121 Urokinase Streptokinase Pulmonary Embolism Trial. Phase II results.  JAMA . 1974;  229 1606-1613
• 122 Levine M, Hirsch J, Weitz J I. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.  Chest . 1990;  98 1473-1479
• 123 Dalla-Volta S, Palla A, Santolicandro A. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2.  J Am College Cardiol . 1992;  20 520-526
• 124 Dalen J E, Alpert J S, Hirsh J. Thrombolytic therapy for pulmonary embolism: is it effective?.  <~>Is it safe? <~>When is it indicated? Arch Intern Med . 1997;  157 2550-2556
• 125 Mikkola K M, Patel S R, Parker J A. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.  Am Heart J . 1997;  134 69-72
• 126 Hyers T M, Hull R D, Weg J G. Antithrombotic therapy for venous thromboembolic disease.  Chest . 1992;  102 408S-425S
• 127 ACCP Consensus Committee on Pulmonary Embolism. Opinions regarding the diagnosis and management of venous thromboembolic disease.  Chest . 1996;  109 233-237
• 128 Konstantinides S, Geibel A, Olschewshi M. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Results of a multicenter registry.  Circulation . 1997;  96 882-888
• 129 Kasper W, Konstantinides S, Geibel A. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism.  Heart . 1997;  77 346-349
• 130 Goldhaber S Z, Visani L, DeRosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER).  Lancet . 1999;  353 1386-1389
• 131 Ribeiro A, Lindmarker P, Juhlin-Dannfelt A. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate.  Am Heart J . 1997;  134 479-487
• 132 Greenfield L J, Rutherford R B. Recommended reporting standards for vena caval filter placement and patient follow-up. Vena Caval Filter Consensus Conference.  J Vasc Intervent Radiol . 1999;  10 1013-1019
• 133 Fink J A, Jones B T. The Greenfield filter as the primary means of therapy in venous thromboembolic disease.  Surg Gynecol Obstet . 1991;  172 253-292
• 134 Leach T A, Pastena J A, Swan K G. Surgical prophylaxis for pulmonary embolism.  Am Surg . 1994;  60 292-295
• 135 Dorfman G S. Percutaneous inferior vena caval filters.  Radiology . 1990;  174 987-992
• 136 Greenfield L J, Proctor M C. Suprarenal filter placement.  J Vasc Surg . 1998;  28 432-438
• 137 Tola J C, Holtzman R, Lottenberg L. Bedside placement of inferior vena cava filters in the intensive care unit.  Am Surg . 1999;  65 833-837
• 138 Linsenmaier U, Rieger J, Schenk F. Indications, management, and complications of temporary inferior vena cava filters.  Cardiovasc Intervent Radiol . 1998;  21 464-469
• 139 Spence L K, Gironta M G, Malde H M. Acute upper extremity deep venous thrombosis: Safety and effectiveness of superior vena caval filters.  Radiology . 1999;  210 53-58
• 140 Greenfield L J, Cho K J, Proctor M C. Results of a multicenter study of the modified hook-titanium Greenfield filter.  J Vasc Surg . 1991;  14 253-257
• 141 Decousus H, Leizorovicz A, Parent F. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.  N Engl J Med . 1998;  338 409-415
• 142 Hubbard K P, Roehm Jr O J, Abbruzzese J L. The bird's nest filter: an alternative to long-term oral anticoagulation in patients with advanced malignancies.  Am J Clin Oncol . 1994;  17 115-117
• 143 Lord R S, Benn I. Early and late results after bird's nest filter placement in the inferior vena cava: clinical and duplex ultrasound follow up.  Aust N Z J Surg . 1994;  64 106-114
• 144 Murphy T P, Dorfman G S, Yedicka J W. LGM vena cava filter: objective evaluation of early results.  J Vasc Intervent Radiol . 1991;  2 107-115
• 145 Millward S F, Peterson R A, Moher D. LGM (Vena Tech) vena caval filter: experience at a single institution.  J Vasc Intervent Radiol . 1994;  5 351-356
• 146 Crochet D P, Brunel P, Trogrlic S. Long-term follow-up of vena tech-LGM filter: predictors and frequency of caval occlusion.  J Vasc Intervent Radiol . 1999;  10 137-142
• 147 Bull P G, Mendel H, Schlegl A. Gunther vena caval filters: clinical appraisal.  J Vasc Intervent Radiol . 1992;  34 395-399
• 148 Meyer G, Tamisier D, Sors H. Pulmonary embolectomy: a 20-year experience at one center.  Ann Thorac Surg . 1991;  51 232-236
• 149 Gray H H, Morgan J M, Paneth M. Pulmonary embolectomy for acute massive pulmonary embolism: an analysis of 71 cases.  Br Heart J . 1988;  60 196-200
• 150 Clarke D B, Abrams L D. Pulmonary embolectomy: a 25 year experience.  J Thorac Cardiovasc Surg . 1986;  92 442-445
• 151 Ullmann M, Hemmer W, Hannekum A. The urgent pulmonary embolectomy: mechanical resuscitation in the operating theatre determines the outcome.  Thorac Cardiovasc Surg . 1999;  47 5-8
• 152 Stewart J R, Greenfield L J. Transvenous vena caval filtration and pulmonary embolectomy.  Surg Clin North Am . 1982;  62 411-430
• 153 Timsit J F, Reynaud P, Meyer G. Pulmonary embolectomy by catheter device in massive pulmonary embolism.  Chest . 1991;  100 655-658
• 154 Koning R, Cribier A, Gerber L. A new treatment for severe pulmonary embolism: percutaneous rheolytic thrombectomy.  Circulation . 1997;  96 2498-2500
• 155 Fava M, Loyola S, Flores P. Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism.  J Intervent Radiol . 1997;  8 261-266
• 156 Claggett G P, Anderson Jr A F, Geerts W. Prevention of venous thromboembolism.  Chest . 1998;  114 531S-560S
• 157 Mismetti P, Laporte-Simitsidis S, Tardy B. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials.  Thromb Haemost . 2000;  83 14-19
• 158 Hirsch D R, Ingenito E P, Goldhaber S Z. Prevalence of deep venous thrombosis among patients in medical intensive care.  JAMA . 1995;  274 335-337
• 159 Pingleton S K, Bone R C, Pingleton W W. Prevention of pulmonary emboli in a respiratory intensive care unit: efficacy of low-dose heparin.  Chest . 1981;  79 647-650
• 160 Geerts W H, Jay R M, Code K I. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.  N Engl J Med . 1996;  335 701-707
• 161 Greenfield L J, Proctor M C, Rodriguez J L. Posttrauma thromboembolism prophylaxis.  J Trauma Injury Infect Crit Care . 1997;  42 100-103
• 162 Knudson M, Morabito D, Paiement G D. Use of low molecular weight heparin in preventing thromboembolism in trauma patients.  J Trauma Injury Infect Crit Care . 1996;  41 446-459
• 163 Hull R, Raskob G, Pineo G. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.  N Engl J Med . 1993;  329 1370-1376
• 164 Bergqvist D, Benoni G, Bjorgell O. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.  N Engl J Med . 1996;  335 696-700
• 165 Modig J, Borg T, Karlstrom G. Thromboembolism after total hip replacement: role of epidural and general anesthesia.  Anesth Analg . 1983;  62 174-180
• 166 McKenzie P J, Wishart H Y, Gray I. Effects of anaesthetic technique on deep vein thrombosis. A comparison of subarachnoid and general anaesthesia.  Br J Anaesth . 1985;  57 853-857
• 167 Collins R, Scrimgeour A, Yusuf S. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.  N Engl J Med . 1988;  318 1162-1173
• 168 Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary Embolism Prevention (PEP) trial.  Lancet . 2000;  355 1295-1302
• 169 Sors H, Meyer G. Place of aspirin in prophylaxis of venous thromboembolism.  Lancet . 2000;  355 1288-1289
• 170 Stratton M A, Anderson F A, Bussey H I. Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients.  Arch Intern Med . 2000;  160 334-340
• 171 Wells P S, Anderson D R, Bormanis J. Value of assessment of pretest probability of deep vein thrombosis in clinical management.  Lancet . 1997;  350 1795-1798
• 172 Wells P S, Ginsberg J S, Anderson D R. Use of clinical model for safe management of patients with suspected pulmonary embolism.  Ann Intern Med . 1998;  129 997-1005
• 173 Miniati M, Prediletto R, Formichi B. Accuracy of clinical assessment in the diagnosis of pulmonary embolism.  Am J Respir Crit Care Med . 1999;  159 864-871
• 174 Patil S, Henry J W, Rubenfire M. Neural network in the clinical diagnosis of acute pulmonary embolism.  Chest . 1993;  104 1685-1689
• 175 Tourassi G D, Floyd C E, Coleman R E. Improved noninvasive diagnosis of acute pulmonary embolism with optimally selected clinical and chest radiographic findings.  Acad Radiol . 1996;  3 1012-1018

1 *A diligent, but not exhaustive, search was made for the appropriate references in this section.